Physician profile
Peter S Conti
NPI 1689613762
$66,831.04
in general payments reported to CMS, 2019-2025
10 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Nuclear Radiology provider received nationally (typical 2025 total: $145).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $26K · 2021: $9,868 · 2022: $14K · 2023: $2,007 · 2024: $1,695 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,619 · Consulting Fee: $1,375 · Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,618.80 |
| Consulting Fee | $1,375.00 |
| Food and Beverage | $973.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $21,200.00 | 2020-2021 | |
| Canon Medical Systems USA, INC. | $15,058.20 | 2019-2021 | |
| Ge Healthcare | $14,367.60 | 2020-2025 | |
| Siemens Medical Solutions USA, INC. | $11,253.02 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $2,900.00 | 2019-2024 | |
| Telix Pharmaceuticals | $1,653.42 | 2023 | Illuccix |
| Progenics Pharmaceuticals, INC. | $188.44 | 2022-2023 | Pylarify |
| Advanced Accelerator Applications | $110.00 | 2019 | |
| Avid Radiopharmaceuticals, INC. | $85.00 | 2019 | |
| United Imaging Healthcare North America LLC | $15.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Conti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.